115 related articles for article (PubMed ID: 10101247)
1. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Apr; 67(1):190-3. PubMed ID: 10101247
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
Gresch PJ; Walker PD
Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 2A and 2C receptor biosynthesis in the rodent striatum during postnatal development: mRNA expression and functional linkage to neuropeptide gene regulation.
Basura GJ; Walker PD
Synapse; 2000 Nov; 38(2):216-25. PubMed ID: 11018795
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
Gresch PJ; Walker PD
Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
[TBL] [Abstract][Full Text] [Related]
6. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
Yamada J; Sugimoto Y; Yoshikawa T
Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of tachykinin vs. enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development.
Basura GJ; Walker PD
Brain Res Dev Brain Res; 1999 Jan; 112(1):155-7. PubMed ID: 9974171
[TBL] [Abstract][Full Text] [Related]
8. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):80-91. PubMed ID: 11000480
[TBL] [Abstract][Full Text] [Related]
9. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
10. Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures.
Campbell BM; Walker PD
Brain Res; 2001 Jan; 888(1):26-33. PubMed ID: 11146049
[TBL] [Abstract][Full Text] [Related]
11. P-chloroamphetamine induces c-fos in rat brain: a study of serotonin2A/2C receptor function.
Moorman JM; Leslie RA
Neuroscience; 1996 May; 72(1):129-39. PubMed ID: 8730712
[TBL] [Abstract][Full Text] [Related]
12. Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice.
Sugimoto Y; Ohkura M; Inoue K; Yamada J
Eur J Pharmacol; 2001 Nov; 430(2-3):265-8. PubMed ID: 11711040
[TBL] [Abstract][Full Text] [Related]
13. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
Yamada J; Sugimoto Y; Ohkura M; Inoue K
Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
[TBL] [Abstract][Full Text] [Related]
14. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission.
Walker PD; Capodilupo JG; Wolf WA; Carlock LR
Brain Res; 1996 Sep; 732(1-2):25-35. PubMed ID: 8891265
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; De Deurwaerdére P; Di Mascio M; Di Matteo V; Esposito E; Spampinato U
Neuroscience; 1999; 91(2):587-97. PubMed ID: 10366016
[TBL] [Abstract][Full Text] [Related]
16. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
De Deurwaerdère P; Spampinato U
J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons.
Gardier AM; Moratalla R; Cuéllar B; Sacerdote M; Guibert B; Lebrec H; Graybiel AM
J Neurochem; 2000 Apr; 74(4):1363-73. PubMed ID: 10737591
[TBL] [Abstract][Full Text] [Related]
18. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
19. Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion.
Horner KA; Adams DH; Hanson GR; Keefe KA
Neuroscience; 2005; 131(1):67-77. PubMed ID: 15680692
[TBL] [Abstract][Full Text] [Related]
20. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
